Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aso InternationalTSE:9340 +6.94%67 EV-to-EBITDA is 7.62 as of Aug. 30, 2026, which is 9% above its 10-year median of 6.97. GuruFocus rates TSE:9340 with a GF Score™ of 67/100 and a GF Value™ of 円674.96 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 520 Medical Devices & Instruments companies, Aso International ranks better than 75.96% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aso International's enterprise value is 円5,666 Mil.
Aso International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円744 Mil. Therefore, Aso International's EV-to-EBITDA for today is 7.62.
The historical rank and industry rank for Aso International's EV-to-EBITDA or its related term are showing as below:
TSE:9340'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.5 Med: 6.97 Max: 13.69
Current: 7.62
During the past 6 years, the highest EV-to-EBITDA of Aso International was 13.69. The lowest was 2.50. And the median was 6.97.
TSE:9340's EV-to-EBITDA is ranked better than 75.96% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.66
vs TSE:9340: 7.62
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Aso International (TSE:9340) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aso International's PE Ratio (TTM) for today is calculated as:
Aso International's share price for today is 円770.00.
Aso International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円51.940.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Aso International's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9340 vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Aso International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aso International EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aso International's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aso International's EV-to-EBITDA falls into.
Aso International's current Enterprise Value is 円5,666 Mil.
Aso International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円744 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aso International (TSE:9340) has a EV-to-EBITDA of 7.62 as of Aug. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aso International. This is near median its historical median of 6.97. Over the past decade, Aso International's EV-to-EBITDA has ranged from 2.50 to 13.69. According to the industry distribution chart, Aso International ranks #125 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 24%.
Is Aso International's EV-to-EBITDA too high?
Aso International's current EV-to-EBITDA of 7.62 is near median its 10-year median of 6.97. Over the past 10 years, this metric has ranged from a low of 2.50 to a high of 13.69. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.66. Aso International's value of 7.62 is 48% below this industry median. Based on the distribution chart, Aso International ranks #125 out of 520 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aso International has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aso International's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aso International ranks #125 out of 520 companies for EV-to-EBITDA. This places Aso International in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.66. Aso International's value of 7.62 is 48% below this benchmark. Historically, Aso International's own EV-to-EBITDA has ranged from 2.50 to 13.69 over the past decade. While the company's 10-year median is 6.97 vs. the industry median of 14.66, Aso International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.66, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aso International's current EV-to-EBITDA of 7.62 is 48% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aso International. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aso International's current EV-to-EBITDA is 7.62, which is near median its own 10-year median of 6.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aso International stock overvalued right now?
Based on GuruFocus' analysis, Aso International (TSE:9340) is currently considered Modestly Overvalued. The stock's GF Value™ is 円674.96, compared to a current price of 円770.00 — trading 14.1% above its estimated fair value. The current EV-to-EBITDA is 7.62, which is near median its 10-year median of 6.97 and 48% below the Medical Devices & Instruments industry median of 14.66. Aso International's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Aso International (TSE:9340), the current EV-to-EBITDA is 7.62 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aso International (TSE:9340) Overvalued in 2026?
Based on GuruFocus' analysis, Aso International stock appears to be overvalued.
The current stock price of 円770.00 is trading 14.1% above its estimated GF Value™ of 円674.96.
GuruFocus considers Aso International to be Modestly Overvalued.
Key valuation signals for TSE:9340:
EV-to-EBITDA: 7.62 (near median its 10-year median of 6.97)
GF Value™: 円674.96 vs. price of 円770.00 (14.1% above fair value)
Industry Position: 48% below the Medical Devices & Instruments median (#125 of 520)
No single metric tells the full story. See the TSE:9340 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aso International Inc is engaged in the manufacturing and sale of orthodontic appliances. The company mainly manufactures and supplies custom-made orthodontic dental prostheses to dental medical institutions. Its product portfolio comprises Aso Liner, Specter 4D Print Retainer, 3D printers for dental prostheses, Harmony, a lingual orthodontic system, and various types of retainers, among others. The group operates in a single segment, the orthodontic business.
67GF Score
Get the complete analysis for TSE:9340
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9340 has been successfully added to your 
